Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer Artificial intelligence (AI) ...

Investors are reassessing fragmented implementation models as portfolio complexity, liquidity demands, and market risks grow. A total portfolio mindset is driving greater use of overlays, completion ...

AI is top of mind for executives across every industry, with a 2023 Bloomberg report predicting that generative AI could become a $1.3 trillion market by 2032. As AI tools continue to pop up and ...

NASHVILLE, TN, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Creative Health Care Insight (CHCI) has just announced the formalization of its strategic partnership model, an expanded approach designed to help ...